Check-Cap Narrows MBody AI Merger Timeline to Q3 2026, Within Eight Weeks
MBAI sits 100% above its 52-week low of $0.593 on elevated volume (1.9× avg).
Summary
Check-Cap now expects its merger with MBody AI to close within eight weeks, by the end of Q3 2026, after responding to all SEC comments and clearing Nasdaq's initial listing review. The update narrows prior guidance and signals the deal is nearing completion.
Key Events · M&A and Partnerships · MBAI
-
Merger Timeline Narrowed to Q3 2026
The MBody AI merger is now expected to close within eight weeks, by the end of Q3 2026, updating prior guidance of 'second half of 2026.'
-
SEC Review Completed
All SEC staff comments on the Form 20-F and Form F-1 registration statement have been responded to, clearing a key regulatory hurdle.
-
Nasdaq Listing Application Progressed
Nasdaq completed its initial review of the listing application, and all questions have been responded to, moving the process closer to final approval.
-
Closing Conditions Substantially Met
Substantially all closing conditions within the parties' control have been satisfied, leaving only SEC effectiveness and final Nasdaq approval.
Analysis · MBAI · Industrial Applications And Services
The merger timeline has been tightened from the broad 'second half of 2026' to a specific eight-week window ending in Q3 2026. All SEC comments have been addressed, the Nasdaq listing application has cleared initial review, and substantially all closing conditions within the parties' control are satisfied. While the deal still hinges on SEC effectiveness and final Nasdaq approval, the narrowed timeline and completed regulatory steps reduce uncertainty and signal that the merger is on track. For a micro-cap company with a pending transformative merger, this progress update is a meaningful de-risking event.
At the time of this filing, MBAI was trading at $1.19 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $9.1M. The 52-week trading range was $0.59 to $3.92. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.